M. Zafar, MD, SC, is a leading internal medicine practice serving the Central Illinois community and beyond with offices in Streator and Flanagan. The practice is led by Muhammad Zafar, MD, who has over fifty years of experience working as a board-certified physician.

Dr. Zafar obtained his medical degree from King Edward Medical University in Lahore, Pakistan, in 1969. He completed his post-medical residency in Internal Medicine and fellowships in Hematology and Oncology at Cook County Hospital in Chicago, Illinois.

Patients trust Dr. Zafar because he has an extensive knowledge base and practical experience treating patients with various illnesses. M. Zafar, MD, SC, offers oncology care for blood cancers and other hematological malignancies. In addition to hematology, the practice provides medical weight loss support with Semaglutide (the active ingredient of Ozempic™ and Wegovy™) and Tirzepatide (the active ingredient of Mounjaro™). 

Dr. Zafar is a highly skilled physician who truly believes in being available to patients and their families. He is dedicated to staying up to date with trends in modern medicine to deliver patient care based on the latest research.

In his free time, Dr. Zafar enjoys watching the Chicago Bulls and Bears, gardening, and spending time with his grandchildren.

Revitalize your health journey with the comprehensive medical weight loss services at M. Zafar, MD, SC, serving Illinois statewide by Telehealth. Led by Dr. Muhammad Zafar, MD, the practice offers personalized and innovative weight loss strategies, including the use of Semaglutide (the active ingredient of Ozempic™ and Wegovy™) and Tirzepatide (the active ingredient of Mounjaro™). At M. Zafar, MD, SC, we strive to foster an environment where patients feel heard, understood, and confident in their health journey. Trust us to be your partner in health, paving the path to well-being through superior medical care.

Moovcare® is a medical application that needs to be prescribed by your oncologist and helps you stay connected to your medical team. If your physician determines that you are eligible to be included into Moovcare® platform, you will start receiving a digital questionnaire once a week, which you can answer via your smartphone, laptop or tablet.

You will be required to self report your symptoms, Moovcare® algorithm will analyse your answers and if it detects an anomaly or complication, an immediate notification will be sent to your treating physician. Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

Moovcare® was proven in a clinical study to significantly improve lung cancer patients’ well being, as well as the communication with the medical team.